Datametrex AI Secures FDA Authorizations For Two COVID-19 Test Kits

Datametrex AI (TSXV: DM) has expanded its target market for COVID-19 test kits. The company announced this morning that two of its test kit offerings have recently received US FDA authorization under Emergency Use Authorizations for Medical Devices (EUA).

Datametrex AI's Logo

The first kit, produced by Seasun Biomaterial, is a 20 minute rapid Nucleic Acid test kit. The kit, referred to as AQ-TOP COVID-19 Rapid Detection Kit, expedites the process of testing via reduced testing times which assists in detecting the virus earlier than other offerings. The kit also provides a more accurate prediction of positive cases.

The second offering is that of the popular 1drop Inc test kit which has been in high demand from Canadian mining firms, as demonstrated by yesterdays announcement of a $450,000 purchase order. 1drop’s 1copy COVID-19 qPCR Multi Kit has also seen FDA authorization under the EUA program with the US FDA. The multi kit is also a nucleic test kit, providing results in less than two hours via the use of swabs.

"Having seen the urgent need for COVID-19 test kits, Datametrex is doing everything it can to help Canada combat COVID-19 and flatten the curve. In the meantime, having FDA under EUA approved test kits allow us to help our neighbours to the south and any Canadian company with operations in the US." 
Marshall Gunter, CEO Datametrex

The company now has three different COVID-19 test kit offerings that have received FDA approval under the Coronavirus Disease 2019 Emergency Use Authorizations for Medical Devices that it is able to sell across the US. In addition to the 1copy and AQ-Top test kits, the company also has the rights to sell the Seasun U-TOP COVID-19 Detection Kit.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Datametrex AI last traded at $0.12 on the TSX Venture.


FULL DISCLOSURE: Datametrex AI is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Datametrex AI on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Majestic Hits 4.24 g/t Gold Over 48.8 Metres at Saval as Jerritt Canyon Restart Advances

First Majestic Lifts Q3 Revenue 38% to US$394.1 Million on Higher Silver Prices

Related News

CloudMD’s Livecare Added To Approved Vendor Lists For Leading Government Associations

CloudMD Software & Services (CSE: DOC) this morning updated the market on the significant growth...

Thursday, April 30, 2020, 09:00:17 AM

Initial Jobless Claims in the US Continue to Surpass Economists’ Forecasts

Although the US economy was beginning to show signs of a rebound, the positive sentiment...

Friday, June 26, 2020, 03:33:00 PM

Datametrex Acquires Firm Focused On EV Charging Infrastructure

Datametrex AI (TSXV: DM) is evidently entering into a new vertical. The firm this morning...

Thursday, June 9, 2022, 07:57:27 AM

Datametrex AI Lands Four New Shows For Its COVID Testing Service Until Mid-2022

Datametrex AI Limited (TSXV: DM) announced today that it has signed four additional service agreements...

Friday, July 23, 2021, 09:45:00 AM

Revive Expects To Complete Phase 3 Interim Analysis In December On Bucillamine In Treatment of COVID-19

Revive Therapeutics (CSE: RVV) provided an update on the status of its ongoing phase three...

Monday, October 26, 2020, 10:54:38 AM